高剂量左氧氟沙星序贯法治疗呼吸道感染的临床观察被引量：2

下载PDF

导出

摘要目的观察高剂量左氧氟沙星序贯法治疗呼吸道感染的临床效果。方法将呼吸道感染患者58例随机分为观察组29例和对照组29例。观察组采用左氧氟沙星序贯疗法;对照组先给予头孢他啶后改用阿莫西林/克拉维酸钾治疗。比较2组的治疗效果。结果观察组治愈率与总有效率分别为72.41%和89.66%,对照组分别为68.97%和86.21%,2组差异均无统计学意义(P>0.05);2组细菌清除率相比,差异无统计学意义(P>0.05)。结论高剂量左氧氟沙星序贯治疗呼吸道感染的疗效明显、安全可靠,值得临床推广。

作者郭玉红

机构地区河南省偃师市妇幼保健院儿科

出处《临床合理用药杂志》 2010年第14期61-61,共1页 Chinese Journal of Clinical Rational Drug Use

关键词左氧氟沙星呼吸道感染序贯疗法

分类号 R56 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献2

1高钧.氟喹诺酮类药物的临床应用进展[J].中国临床药理学杂志,2005,21(3):229-232. 被引量：20
2刘又宁.新喹诺酮在社区获得性呼吸道感染中的应用价值[J].中华结核和呼吸杂志,2002,25(12):748-752. 被引量：25

二级参考文献27

1Ramirez J A, Mgayen T.Treating community-acqured pneumonia with once- daily gatifloxacin VS twice-daily clarithromycin. J Respir Dis, 1999, 20:s60-69.
2Forrest A, Nix DE,Ballow CH, et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother, 1993, 37:1073-1081
3Lode H, Borner K, Koeppe P. Pharmacodynamics of fluoroquinolones. Clin Infect Dis , 1998, 27:33-39.
4Dalnoff A. Pharmacodymics of fluoquinolones. J Antimicrob Chemother, 1999, 43:51-59.
5Ruiz-Gonzalez A, Falguera M,Nogues A, et al. Is streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia.Am J Med, 1999, 106:385-390.
6Niederman MS, Mandell LA, Anzueto A, et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med, 2001,163:1730-1754.
7Davies BI, Maesen FP. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. J Antimicrob Chemother, 1999, 43 Supple C:83-90.
8DeAbate CA, Russell M, et al. Safety and efficacy if oral levofloxacin versus cefuroxime axetil in acute bacterial exacerbations of chronic bronchitis. Respir Care, 1999, 42:206-213.
9Ramirez A, Molina J, et al. Gatifloxacin treatment in patients with acute exacerbation of chronic bronchitis: clinical trial results. J Respir Dis, 1999, 20: S 30-39.
10File TM Jr, Segreti J, Dunbar L,et al. A multi-center, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired penumonia, Antimicrob Agents Chemother, 1997, 41:1965-1972.